Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 45 of 619 for:    oximeter

Validation and Characterization of Signal Decrease on an Oximeter in COPD (They Have Chronic Obstructive Pulmonary Disease) Patients During Deep Inhalation ( (OXYMETRE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03966196
Recruitment Status : Completed
First Posted : May 29, 2019
Last Update Posted : May 29, 2019
Sponsor:
Information provided by (Responsible Party):
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Brief Summary:
The objective is to verify that there is a decrease in the pulsed oxygen saturation with the digital sensor. That is, the drop in oxygen saturation in COPD patients during inhalation is real and not due to an artifact of the measuring tool, because oximeters need a quality pulsatile signal to properly measure oxygen saturation

Condition or disease Intervention/treatment Phase
Pulmonary Disease Copd Other: Measurements of oxygen saturation and finger pressure during deep inspiration Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 12 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: half healthy subject, half COPD patients
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Validation and Characterization of Signal Decrease on an Oximeter in Chronic Obstructive Pulmonary Disease
Actual Study Start Date : February 11, 2019
Actual Primary Completion Date : May 10, 2019
Actual Study Completion Date : May 10, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Healthy Volunteers
oxymetry and finger pressure in Healthy subjects
Other: Measurements of oxygen saturation and finger pressure during deep inspiration
Measurements during deep inspiration of oxygen saturation with pulse oximeter and finger pressure with pressure cuff

Experimental: COPD patients
oxymetry and finger pressure in COPD patients
Other: Measurements of oxygen saturation and finger pressure during deep inspiration
Measurements during deep inspiration of oxygen saturation with pulse oximeter and finger pressure with pressure cuff




Primary Outcome Measures :
  1. drop in oxygen saturation during deep inspiration in COPD [ Time Frame: from the intervention to 3 minutes after the start of the intervention ]
    saturation is measured in percentage (SPO2)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

healthy arm

Inclusion Criteria:

  • Healthy adults volunteers are recruited from students with normal lung function.

Exclusion Criteria:

  • abnormal lung function

COPD Arm

Inclusion Criteria:

  • Adults with Chronic Obstructive pulmonary disease

Exclusion Criteria:

  • cardiovascular disease

The subjects selected are selected on a voluntary basis among the patients coming to the pulmonary consultation. They have Chronic Obstructive Pulmonary Disease.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03966196


Locations
Layout table for location information
Belgium
Cliniques universitaires Saint-Luc
Brussels, Belgium, 1200
Sponsors and Collaborators
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Investigators
Layout table for investigator information
Principal Investigator: Giuseppe Liistro, PhD, MD Cliniques universitaires Saint-Luc

Layout table for additonal information
Responsible Party: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
ClinicalTrials.gov Identifier: NCT03966196     History of Changes
Other Study ID Numbers: 2018/25AVR/185
First Posted: May 29, 2019    Key Record Dates
Last Update Posted: May 29, 2019
Last Verified: May 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain:
COPD
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases